Author:
Dhere Vishal R.,Goyal Subir,Zhou Jun,Sebastian Nikhil T.,Patel Ashish B.,Hanasoge Sheela,Patel Pretesh R.,Shelton Joseph,Godette Karen D.,Hershatter Bruce W.,Jani Ashesh B.,Patel Sagar A.
Funder
Winship Cancer Institute
National Institutes of Health
National Cancer Institute
Reference29 articles.
1. Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer;Michalski;JAMA Oncol,2018
2. Long-term results of the MD Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int J Radiat Oncol,2008
3. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09;Zietman;J Clin Oncol,2010
4. Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer;Talcott;JAMA,2010
5. Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the University of Florida Proton Therapy Institute;Colaco;Int J Radiat Oncol,2015